Medical Devices

A new partnership expands patient choice in Europe, but the real story is a strategic power play in the $100B+ diabetes market. Here’s why it matters.

After completing massive studies, the Utah firm is readying an FDA submission that could move gold-standard diagnostics from the lab to your local clinic.

A Singapore-based company has patented a device to end large incisions in colorectal surgery, promising fewer infections and faster patient recovery.

STARMED secures a landmark FDA clearance for its thyroid RFA system, the first of its kind, promising a minimally invasive alternative to surgery.

With €7.5M from Europe’s top innovation fund, a Belgian startup is not just correcting vision—it’s turning the eye into a window for our overall health.

Beyond the circuit board, Kimball Electronics acquires a polymer specialist, signaling a major shift toward building the physical infrastructure for global health.

A groundbreaking study reveals high-tech communication aids boost quality of life by 65% and offer a 3.3x economic return, proving that investing in accessibility is smart strategy.

The global MRI market is shifting from a hardware race to a software game. AI, low-helium systems, and workflow automation are the new keys to success.

A $23 pocket device claims to kill bug bite itch with heat. We go beyond the hype to analyze the science, the market, and the real-world trade-off.

A new study shows Candela's Nordlys laser not only reverses skin aging at a DNA level but may also fight cancer, setting a new bar for the industry.

By partnering with manufacturing giant Sanmina, Microbot Medical is telegraphing its shift from a promising MedTech firm to a serious global contender.

Thirty women have received a revolutionary absorbable scaffold that uses their own fat to regenerate breast tissue, promising an end to implant-related risks.

Saluda Medical secures FDA approval for its CAP24™ paddle lead, expanding its advanced closed-loop neuromodulation to surgeons and chronic pain patients.

Exact Imaging's U.S. expansion signals a major shift. With technology rivaling MRI, micro-ultrasound is poised to make precision diagnostics more accessible.

As new treatments for degenerative eye disease emerge, OpZira's hiring of a key innovator from its past signals a major push into AI-driven diagnostics.

Novocure's Optune Pax device, using Tumor Treating Fields, gains European approval, offering extended survival and significant pain relief for a deadly disease.

A landmark public-private partnership brings next-gen proton therapy to Portugal, ending medical exile for patients and creating a new European oncology hub.

With FDA approval for its pivotal TRIUMPH trial, Laplace Interventional is challenging giants in the lucrative tricuspid valve market. A strategic play.

Onkos Surgical hit 500 cases with its NanoCept antibacterial coating. Is this nano-scale tech the key to winning the war on devastating surgical infections?